VEGFA and rheumatoid arthritis: As HIFs regulate a plethora of downstream angiogenic factors including VEGF, in response to hypoxia and inflammatory cytokines, the efficacy of anti-TNFα therapy could, at least in part, be due to a reduction in the activation of HIF leading to decreased angiogenesis and less immature synovial vessels in RA patients.